Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Reports of Regulated Transactions Involving Extraordinary Quantities, Uncommon Methods of Payment, and Unusual/Excessive Loss or Disappearance, and Regulated Transactions in Tableting/Encapsulating Machines, 18256-18257 [2015-07666]
Download as PDF
<![CDATA[
18256
Federal Register / Vol. 80, No. 64 / Friday, April 3, 2015 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
in section 210.10 of the Commission’s Rules
of Practice and Procedure, 19 CFR 210.10
(2014).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
March 30, 2015, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain wireless standard
compliant electronic devices, including
communication devices and tablet
computers, by reason of infringement of
one or more of claims 1, 2, 4, 6, 7, 9,
11–13, 15–19, 21, and 22 of the ’996
patent; claims 7–12 and 18–23 of the
’270 patent; claims 28–54 of the ’359
patent; claims 1, 8–10, 12, 23, 24, 26, 27,
29–31, 38–40, 42, 49, 50, 52, 53, 57, 58,
64–66, and 68 of the ’556 patent; claims
19, 20, 22–27, and 29–32 of the ’805
patent; claims 1, 3, 5–8, 10, and 12–15
of the ’130 patent; claims 1, 2, 4, 5, 7,
11, and 13–15 of the ’381 patent; and
claims 1, 3, 4, 6, 8, 9, 11, 12, 14, 16, 25,
and 26 of the ’476 patent; and whether
an industry in the United States exists
as required by subsection (a)(2) of
section 337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding administrative law judge shall
take evidence or other information and
hear arguments from the parties and
other interested persons with respect to
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1).
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are: Ericsson
Inc., 6300 Legacy Drive, Plano, TX
75024.
Telefonaktiebolaget LM Ericsson,
Torshamnsgatan 21, Kista, Stockholm,
Sweden.
(b) The respondent is the following
entity alleged to be in violation of
section 337, and is the party upon
which the complaint is to be served:
Apple Inc., a/k/a Apple Computer, Inc.,
1 Infinite Loop, Cupertino, CA 95014.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
VerDate Sep<11>2014
17:49 Apr 02, 2015
Jkt 235001
Commission, 500 E Street SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
A response to the complaint and the
notice of investigation must be
submitted by the named respondent in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such a
response will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting a response to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of the respondent to file a
timely response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: March 30, 2015.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2015–07647 Filed 4–2–15; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0024]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Reports of
Regulated Transactions Involving
Extraordinary Quantities, Uncommon
Methods of Payment, and Unusual/
Excessive Loss or Disappearance, and
Regulated Transactions in Tableting/
Encapsulating Machines
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-day notice.
AGENCY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 80 FR 6766, February 06,
2015, allowing for a 60 day comment
period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until May 4, 2015.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Reports of Regulated Transactions
Involving Extraordinary Quantities,
Uncommon Methods of Payment, and
Unusual/Excessive Loss or
Disappearance, and Regulated
Transactions in Tableting/Encapsulating
Machines.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Notification of extraordinary quantities,
uncommon methods of payment, and
unusual/excessive loss or disappearance
of listed chemicals and regulated
transactions in tableting/encapsulating
E:\FR\FM\03APN1.SGM
03APN1
Federal Register / Vol. 80, No. 64 / Friday, April 3, 2015 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
machines is provided in writing on an
as needed basis and does not require use
of a form. The applicable component
within the Department of Justice is the
Drug Enforcement Administration,
Office of Diversion Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected public (Primary):
Business or other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Each regulated person is
required to report any regulated
transaction involving an extraordinary
quantity of a listed chemical, an
uncommon method of payment or
delivery, any unusual or excessive loss
or disappearance of a listed chemical,
and any regulated transaction in a
tableting or encapsulating machine, to
include any domestic regulated
transaction in a tableting or
encapsulating machine and any import
or export of a tableting or encapsulating
machine. 21 U.S.C. 830 (b)(1)(A), (C)
and (D); 21 CFR 1310.05(a)(1), (3) and
(4); 21 CFR 1310.05(c).
Regulated persons include
manufacturers, distributors, importers,
and exporters of listed chemicals,
tableting machines, or encapsulating
machines, or persons who serve as
brokers or traders for international
transactions involving a listed chemical,
tableting machine, or encapsulating
machine. 21 CFR 1300.02(b).
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 63
persons respond as needed to this
collection. Responses take 20 minutes.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 21 annual
burden hours.
If additional information is required
please contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2015–07666 Filed 4–2–15; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:49 Apr 02, 2015
Jkt 235001
Overview of This Information
Collection
DEPARTMENT OF JUSTICE
[OMB Number 1117–0012]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection Application for
Registration, Application for
Registration Renewal, Affidavit for
Chain Renewal (DEA Forms 225, 225a
and 225b)
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 80 FR, page 5137, on January
30, 2015, allowing for a 60 day comment
period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until May 4, 2015.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is
necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical
utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions
used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be
collected can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use
of appropriate automated,
electronic, mechanical, or other
forms of information technology,
e.g., permitting electronic
submission of responses.
SUMMARY:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
18257
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Registration,
Application for Registration Renewal,
Affidavit for Chain Renewal.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form numbers are DEA Forms 225,
225a, and 225b. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions, Federal, State, local, and
tribal governments.
Abstract: The Controlled Substances
Act requires all businesses and
individuals who manufacture,
distribute, import, export, and conduct
research and laboratory analysis with
controlled substances to register with
the DEA. 21 U.S.C. 822, 21 CFR 1301.11
and 1301.13. Registration is a necessary
control measure that prevents diversion
by ensuring the closed system of
distribution of controlled substances
can be monitored by the DEA and that
the businesses and individuals handling
controlled substances are qualified to do
so and are accountable.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA Form 225 is only for
registration of controlled substance
manufacturers, distributors, reverse
distributors, importers, exporters,
researchers, canine handlers, and
analytical laboratories, as well as list 1
chemical manufacturers and importers.
DEA Form 225 is submitted on an asneeded basis by persons seeking to
become registered. DEA Form 225a is
submitted annually thereafter to renew
existing registrations. DEA Form 225b is
submitted annually for renewals of
chain registrants. Chain registrants are
those corporations and laboratories that
maintain separate registrations at
multiple locations (e.g., distributors)
and may renew all their registrations
using a single DEA Form 225b.
E:\FR\FM\03APN1.SGM
03APN1
]]>Agencies
[Federal Register Volume 80, Number 64 (Friday, April 3, 2015)]
[Notices]
[Pages 18256-18257]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07666]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0024]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Reports of Regulated Transactions Involving Extraordinary
Quantities, Uncommon Methods of Payment, and Unusual/Excessive Loss or
Disappearance, and Regulated Transactions in Tableting/Encapsulating
Machines
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. This proposed information collection was previously published in
the Federal Register at 80 FR 6766, February 06, 2015, allowing for a
60 day comment period.
DATES: Comments are encouraged and will be accepted for an additional
30 days until May 4, 2015.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Reports of Regulated Transactions
Involving Extraordinary Quantities, Uncommon Methods of Payment, and
Unusual/Excessive Loss or Disappearance, and Regulated Transactions in
Tableting/Encapsulating Machines.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: Notification of extraordinary
quantities, uncommon methods of payment, and unusual/excessive loss or
disappearance of listed chemicals and regulated transactions in
tableting/encapsulating
[[Page 18257]]
machines is provided in writing on an as needed basis and does not
require use of a form. The applicable component within the Department
of Justice is the Drug Enforcement Administration, Office of Diversion
Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Affected public (Primary): Business or other
for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: Each regulated person is required to report any regulated
transaction involving an extraordinary quantity of a listed chemical,
an uncommon method of payment or delivery, any unusual or excessive
loss or disappearance of a listed chemical, and any regulated
transaction in a tableting or encapsulating machine, to include any
domestic regulated transaction in a tableting or encapsulating machine
and any import or export of a tableting or encapsulating machine. 21
U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR 1310.05(a)(1), (3) and (4);
21 CFR 1310.05(c).
Regulated persons include manufacturers, distributors, importers,
and exporters of listed chemicals, tableting machines, or encapsulating
machines, or persons who serve as brokers or traders for international
transactions involving a listed chemical, tableting machine, or
encapsulating machine. 21 CFR 1300.02(b).
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 63 persons respond as needed to this collection. Responses take 20
minutes.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 21 annual burden hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
20530.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2015-07666 Filed 4-2-15; 8:45 am]
BILLING CODE 4410-09-P
